Corden to invest nearly $500M to expand Boulder manufacturing facility
German pharmaceutical manufacturer Corden Pharma International GmbH plans to invest nearly $500 million over the next three years to expand its operations in Boulder in order to produce more GLP-1 peptides, which are components of several increasingly popular weight-loss and diabetes drugs.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
A trio of Boulder startup scene veterans is reviving the local Techstars accelerator program, which…
-
Powdr Corp., Eldora Mountain’s Utah-based parent company, plans to sell the Boulder County ski resort.
-
Medical-device firm Boulder iQ has nearly doubled its Boulder footprint with the purchase of a…
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
